BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 23307060)

  • 1. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.
    Ogino S; Lochhead P; Chan AT; Nishihara R; Cho E; Wolpin BM; Meyerhardt JA; Meissner A; Schernhammer ES; Fuchs CS; Giovannucci E
    Mod Pathol; 2013 Apr; 26(4):465-84. PubMed ID: 23307060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.
    Hamada T; Keum N; Nishihara R; Ogino S
    J Gastroenterol; 2017 Mar; 52(3):265-275. PubMed ID: 27738762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathological epidemiology gives clues to paradoxical findings.
    Nishihara R; VanderWeele TJ; Shibuya K; Mittleman MA; Wang M; Field AE; Giovannucci E; Lochhead P; Ogino S
    Eur J Epidemiol; 2015 Oct; 30(10):1129-35. PubMed ID: 26445996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of molecular pathology, epidemiology and social science for global precision medicine.
    Nishi A; Milner DA; Giovannucci EL; Nishihara R; Tan AS; Kawachi I; Ogino S
    Expert Rev Mol Diagn; 2016; 16(1):11-23. PubMed ID: 26636627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.
    Ogino S; Chan AT; Fuchs CS; Giovannucci E
    Gut; 2011 Mar; 60(3):397-411. PubMed ID: 21036793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology.
    Ogino S; Nowak JA; Hamada T; Milner DA; Nishihara R
    Annu Rev Pathol; 2019 Jan; 14():83-103. PubMed ID: 30125150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.
    Ogino S; Nishihara R; VanderWeele TJ; Wang M; Nishi A; Lochhead P; Qian ZR; Zhang X; Wu K; Nan H; Yoshida K; Milner DA; Chan AT; Field AE; Camargo CA; Williams MA; Giovannucci EL
    Epidemiology; 2016 Jul; 27(4):602-11. PubMed ID: 26928707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.
    Hamada T; Nowak JA; Milner DA; Song M; Ogino S
    J Pathol; 2019 Apr; 247(5):615-628. PubMed ID: 30632609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting social MPE: an integration of molecular pathological epidemiology and social science in the new era of precision medicine.
    Dai J; Nishi A; Tran N; Yamamoto Y; Dewey G; Ugai T; Ogino S
    Expert Rev Mol Diagn; 2021 Sep; 21(9):869-886. PubMed ID: 34253130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.
    Ogino S; Nowak JA; Hamada T; Phipps AI; Peters U; Milner DA; Giovannucci EL; Nishihara R; Giannakis M; Garrett WS; Song M
    Gut; 2018 Jun; 67(6):1168-1180. PubMed ID: 29437869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting.
    Campbell PT; Ambrosone CB; Nishihara R; Aerts HJWL; Bondy M; Chatterjee N; Garcia-Closas M; Giannakis M; Golden JA; Heng YJ; Kip NS; Koshiol J; Liu XS; Lopes-Ramos CM; Mucci LA; Nowak JA; Phipps AI; Quackenbush J; Schoen RE; Sholl LM; Tamimi RM; Wang M; Weijenberg MP; Wu CJ; Wu K; Yao S; Yu KH; Zhang X; Rebbeck TR; Ogino S
    Cancer Causes Control; 2019 Aug; 30(8):799-811. PubMed ID: 31069578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings of the second international molecular pathological epidemiology (MPE) meeting.
    Ogino S; Campbell PT; Nishihara R; Phipps AI; Beck AH; Sherman ME; Chan AT; Troester MA; Bass AJ; Fitzgerald KC; Irizarry RA; Kelsey KT; Nan H; Peters U; Poole EM; Qian ZR; Tamimi RM; Tchetgen Tchetgen EJ; Tworoger SS; Zhang X; Giovannucci EL; van den Brandt PA; Rosner BA; Wang M; Chatterjee N; Begg CB
    Cancer Causes Control; 2015 Jul; 26(7):959-72. PubMed ID: 25956270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings of the third international molecular pathological epidemiology (MPE) meeting.
    Campbell PT; Rebbeck TR; Nishihara R; Beck AH; Begg CB; Bogdanov AA; Cao Y; Coleman HG; Freeman GJ; Heng YJ; Huttenhower C; Irizarry RA; Kip NS; Michor F; Nevo D; Peters U; Phipps AI; Poole EM; Qian ZR; Quackenbush J; Robins H; Rogan PK; Slattery ML; Smith-Warner SA; Song M; VanderWeele TJ; Xia D; Zabor EC; Zhang X; Wang M; Ogino S
    Cancer Causes Control; 2017 Feb; 28(2):167-176. PubMed ID: 28097472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science.
    Ogino S; King EE; Beck AH; Sherman ME; Milner DA; Giovannucci E
    Am J Epidemiol; 2012 Oct; 176(8):659-67. PubMed ID: 22935517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression.
    Lochhead P; Chan AT; Nishihara R; Fuchs CS; Beck AH; Giovannucci E; Ogino S
    Mod Pathol; 2015 Jan; 28(1):14-29. PubMed ID: 24925058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting.
    Yao S; Campbell PT; Ugai T; Gierach G; Abubakar M; Adalsteinsson V; Almeida J; Brennan P; Chanock S; Golub T; Hanash S; Harris C; Hathaway CA; Kelsey K; Landi MT; Mahmood F; Newton C; Quackenbush J; Rodig S; Schultz N; Tearney G; Tworoger SS; Wang M; Zhang X; Garcia-Closas M; Rebbeck TR; Ambrosone CB; Ogino S
    Cancer Causes Control; 2022 Aug; 33(8):1107-1120. PubMed ID: 35759080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, epigenetics and the 'Gloomy Prospect': embracing randomness in population health research and practice.
    Smith GD
    Int J Epidemiol; 2011 Jun; 40(3):537-62. PubMed ID: 21807641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical implications of epigenetics in the era of personalized medicine.
    Santaló J; Berdasco M
    Clin Epigenetics; 2022 Mar; 14(1):44. PubMed ID: 35337378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of inverse probability weighting in molecular pathological epidemiology.
    Liu L; Nevo D; Nishihara R; Cao Y; Song M; Twombly TS; Chan AT; Giovannucci EL; VanderWeele TJ; Wang M; Ogino S
    Eur J Epidemiol; 2018 Apr; 33(4):381-392. PubMed ID: 29264788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma.
    Gao C
    World J Hepatol; 2016 Sep; 8(27):1119-1127. PubMed ID: 27721917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.